TRIM33 and Miyoshi myopathy: TRIM33 loss leads to dysregulated ubiquitination of ALC1, the key regulator of response to PARP inhibition, resulting in the accumulation of endogenous DNA damage and slower DNA repair kinetics in MM cell lines.